welcome
Working for the people to improve healthcare

CIBBIM-Nanomedicine Director

Dr. Simó Schwartz Jr


Nanomedicine and Advanced Therapies as translational sciences have the ultimate goal to provide cost effective novel therapies and diagnostics. As key enable technologies these new options will cause profound changes in healthcare, making feasible more personalized, predictive, preventive, and regenerative medicine.

PRECLINICAL SERVICES

This platform offers standard in vitro experimentation procedures for the functional validation of candidate genes and biomarkers, and for the efficacy and toxicological evaluation of new drugs, biomaterials and biomarkers.
Read more

At the moment, the platform offers standardin vivo experimentation procedures for the evaluation of new therapeutic targets, nanotherapies and biomarkers in the field of oncology and rare diseases.
Read more

Latest
news

News

Second mini-symposium on Cancer Research Omics

Second mini-symposium on Cancer Research Omics

The Vall d’Hebron Research Institute’s Oncology Department (VHIR) has organized the second mini-symposium ‘OMICs in Cancer Research’ in which...

Read more
March 31, World Colorectal Cancer Day

March 31, World Colorectal Cancer Day

On the occasion of World Colorectal Cancer Day, this Sunday, March 31, CIBBIM-Nanomedicine. Biomedical Research in Digestive Tract Tumors of the Institut de Recerca...

Read more
Nanomedicine & Bioengineering

Publications

Sterilization Procedure for Temperature-Sensitive Hydrogels Loaded with Silver Nanoparticles for Clinical Applications

Diana Rafael, Fernanda Andrade, Francesc Martinez-Trucharte, Jana Basas, Joaquín Seras-Franzoso , Marta Palau  Xavier Gomis, Marc Pérez-Burgos , Alberto Blanco, Alba...

Read more